Substituted cinnamic, acid guanidides, process for their preparation, their use as a medicament, and medicament comprising them

US6399824B1 · kind B1 · utility

Assignee

• Aventis Pharma Deutschland GmbH · DE

Inventors

• Armin Hofmeister · Frankfurt, DE
• Max Hropot · Flörsheim, DE
• Uwe Heinelt · Wiesbaden, DE
• Markus Bleich · Brechen, DE
• Hans-Jochen Lang · Hofheim, DE

Key dates

• Filing date: Sep 18, 2001
• Grant date: Jun 4, 2002
• Expiry date: Sep 18, 2021

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D295/13
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Substituted cinnamic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them. Compounds of the formula I which may be obtained by reaction of a compound II with guanidine.